Heidelberg Pharma AG @ Sachs_OIF

Heidelberg Pharma AG presentation by Professor Andreas Pahl, CEO
at the 10th Annual Oncology Innovation Forum
Professor Andreas Pahl, CEO of Heidelberg Pharma is presenting the company and its innovative technologies. Heidelberg Pharma is a dynamic and innovative public clinical-stage biopharmaceutical company specializing in development of Antibody-Drug Conjugates (ADCs). Learn more about the company´s ADC technology platforms and its lead Amanitin-based ADC product candidate HDP-101, for the targeted and highly effective treatment of cancer.
#ADC #cancertherapy #ATAC